These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37640621)

  • 1. Corrigendum to "Salvianolic acid B inhibits hepatic stellate cell activation and liver fibrosis by targeting PDGFRβ" [Int. Immunopharmacol. 122 (2023) 110550].
    Liu F; Li S; Chen P; Gu Y; Wang S; Wang L; Chen C; Wang R; Yuan Y
    Int Immunopharmacol; 2023 Oct; 123():110790. PubMed ID: 37640621
    [No Abstract]   [Full Text] [Related]  

  • 2. Salvianolic acid B inhibits hepatic stellate cell activation and liver fibrosis by targeting PDGFRβ.
    Liu F; Li S; Chen P; Gu Y; Wang S; Wang L; Chen C; Wang R; Yuan Y
    Int Immunopharmacol; 2023 Sep; 122():110550. PubMed ID: 37451016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gomisin D alleviates liver fibrosis through targeting PDGFRβ in hepatic stellate cells.
    Wang R; Liu F; Chen P; Li S; Gu Y; Wang L; Chen C; Yuan Y
    Int J Biol Macromol; 2023 Apr; 235():123639. PubMed ID: 36822287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "Tryptase inhibitor APC 366 prevents hepatic fibrosis by inhibiting collagen synthesis induced by tryptase/protease-activated receptor 2 interactions in hepatic stellate cells" [Int. Immunopharmacol. 20 (2014) 352-357].
    Lu J; Chen B; Li S; Sun Q
    Int Immunopharmacol; 2019 Apr; 69():408. PubMed ID: 30755386
    [No Abstract]   [Full Text] [Related]  

  • 5. Salvianolic acid B blocks hepatic stellate cell activation via FGF19/FGFR4 signaling.
    Tian S; Chen M; Wang B; Han Y; Shang H; Chen J
    Ann Hepatol; 2021; 20():100259. PubMed ID: 32980439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvianolic acid B suppresses hepatic stellate cell activation and liver fibrosis by inhibiting the NF-κB signaling pathway via miR-6499-3p/LncRNA-ROR.
    Wang R; Li S; Chen P; Yue X; Wang S; Gu Y; Yuan Y
    Phytomedicine; 2022 Dec; 107():154435. PubMed ID: 36155216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro.
    Tao YY; Wang QL; Shen L; Fu WW; Liu CH
    Exp Biol Med (Maywood); 2013 Nov; 238(11):1284-96. PubMed ID: 24006304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvianolic acid B inhibits autophagy and activation of hepatic stellate cells induced by TGF-β1 by downregulating the MAPK pathway.
    Jiang N; Zhang J; Ping J; Xu L
    Front Pharmacol; 2022; 13():938856. PubMed ID: 35991894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Hepatic Fibrosis in Mice Based on Targeted Plasmonic Hyperthermia.
    Ribera J; Vilches C; Sanz V; de Miguel I; Portolés I; Córdoba-Jover B; Prat E; Nunes V; Jiménez W; Quidant R; Morales-Ruiz M
    ACS Nano; 2021 Apr; 15(4):7547-7562. PubMed ID: 33720693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scutellariae radix suppresses LPS-induced liver endothelial cell activation and inhibits hepatic stellate cell migration.
    Chen HJ; Liang TM; Lee IJ; Huang YT; Lin YL
    J Ethnopharmacol; 2013 Dec; 150(3):835-42. PubMed ID: 24036165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvianolic Acid B Inhibits Activation of Human Primary Hepatic Stellate Cells Through Downregulation of the Myocyte Enhancer Factor 2 Signaling Pathway.
    Zhang W; Ping J; Zhou Y; Chen G; Xu L
    Front Pharmacol; 2019; 10():322. PubMed ID: 31031620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDGFRβ-targeted TRAIL specifically induces apoptosis of activated hepatic stellate cells and ameliorates liver fibrosis.
    Li R; Li Z; Feng Y; Yang H; Shi Q; Tao Z; Cheng J; Lu X
    Apoptosis; 2020 Feb; 25(1-2):105-119. PubMed ID: 31894448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R.
    Yasuda Y; Shimizu M; Sakai H; Iwasa J; Kubota M; Adachi S; Osawa Y; Tsurumi H; Hara Y; Moriwaki H
    Chem Biol Interact; 2009 Dec; 182(2-3):159-64. PubMed ID: 19646978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum to "Schizandrin inhibits fibrosis and epithelial-mesenchymal transition in transforming growth factor-β1-stimulated AML12 cells" [Int. Immunopharmacol. 25 (2015) 276-284].
    Park JH; Yoon J
    Int Immunopharmacol; 2020 Aug; 85():106747. PubMed ID: 32616385
    [No Abstract]   [Full Text] [Related]  

  • 15. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
    Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
    Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum to "Methyl helicterilate ameliorates alcohol-induced hepatic fibrosis by modulating TGF-β1/Smads pathway and mitochondria-dependent pathway" [Int. Immunopharmacol. 75 (2019) 105759].
    Wen S; Wei Y; Zhang X; Bai F; Tan S; Nie J; Wei J; Lin X
    Int Immunopharmacol; 2021 Mar; 92():107344. PubMed ID: 33418247
    [No Abstract]   [Full Text] [Related]  

  • 17. LincRNA-p21 Inhibits the Wnt/β-Catenin Pathway in Activated Hepatic Stellate Cells via Sponging MicroRNA-17-5p.
    Yu F; Guo Y; Chen B; Shi L; Dong P; Zhou M; Zheng J
    Cell Physiol Biochem; 2017; 41(5):1970-1980. PubMed ID: 28391277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor γ inhibits hepatic stellate cell activation regulated by miR-942 in chronic hepatitis B liver fibrosis.
    Tao L; Wu L; Zhang W; Ma WT; Yang GY; Zhang J; Xue DY; Chen B; Liu C
    Life Sci; 2020 Jul; 253():117572. PubMed ID: 32201276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum to "Gypsophila elegans isoorientin-2″-O-α-L-arabinopyranosyl ameliorates porcine serum-induced immune liver fibrosis by inhibiting NF-κB signaling pathway and suppressing HSC activation" [Int. Immunopharmacol. 54 (2018) 60-67].
    Bai F; Huang Q; Wei J; Lv S; Chen Y; Liang C; Wei L; Lu Z; Lin X
    Int Immunopharmacol; 2023 Sep; 122():110697. PubMed ID: 37500383
    [No Abstract]   [Full Text] [Related]  

  • 20. Adenoviral dominant-negative soluble PDGFRβ improves hepatic collagen, systemic hemodynamics, and portal pressure in fibrotic rats.
    Reichenbach V; Fernández-Varo G; Casals G; Oró D; Ros J; Melgar-Lesmes P; Weiskirchen R; Morales-Ruiz M; Jiménez W
    J Hepatol; 2012 Nov; 57(5):967-73. PubMed ID: 22820479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.